Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

atherosclerosis/phosphatase

Veza se sprema u međuspremnik
14 rezultatima

The Immune System in End Stage CKD Patients - Comparison Among Different Modalities of RRT

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
The sustained inflammatory state in CKD is of complex pathogenesis and is believed to be in part attributable to the augmented activation of innate immune system cell subsets. The activation of the innate immune system plays an essential role within all the spectrum of cardiovascular disease in CKD,

Correlation Between MLR and Risk of Death and Cardiovascular Events in PD Patients.

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
The epidemiological survey of chronic kidney disease in China shows that the current incidence of chronic kidney disease (CKD) in China is about 10.8%, with about 119 million patients. About 2% of patients will enter the stage of end-stage renal disease (ESRD) and require dialysis or kidney

PTP1B Implication in the Vascular Dysfunction Associated With Obstructive Sleep Apnea

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se

Vitamin D Deficiency Treatment Outcomes After Non-ST-Segment Elevation Myocardial Infarction

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
The leading cause of death in the world is due to cardiovascular events, which originate from coronary artery stenosis therefore it affects myocardial blood flow and finally may cause infarction. ST-Segment elevation is an indicator of infarction (STEMI) in electrocardiography (ECG) besides cardiac

ZIMBA: Clinical Trial in Paediatric Obesity

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Study design: A single-center pilot open-label randomized control trial. Population: The study will comprise a total of 60 subjects of both sexes, with pubertal stage ≥ 3 according to the Tanner stage, obese according to the IOTF criteria (International Obesity Task Force), diet naïve or with

Rosuvastatin Effect on Atherosclerotic Plaque Metabolism

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Background: Cardiovascular diseases (CVD) are the main cause of mortality in developed countries; its prevention is challenging. Advances in molecular imaging of the atherosclerotic plaque enhanced the study of its pathophysiology, including the positron emission tomography with computed tomography

Ramipril Treatment of Claudication

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
This is an interventional study of PAD patients that exhibit claudication. The purpose of this study is to determine the potential mechanisms by which Ramipril vastly improves the walking performance of these patients. The study will be achieved through these specific aims: Specific Aim #1: Test the

The BANGALORE Study; Combination of Berberine, Lipoic Acid, and Picrorhiza

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Though medical treatment has been effective in the treatment of cardiometabolic diseases (including coronary atherosclerosis and diabetes mellitus), the incidence of these disorders continues to be high. Many reasons are responsible, but lifestyle changes, including an increased prevalence of

Comparison of Simvastatin Versus Simvastatin/Ezetimibe on Small Dense Low -Density Lipoprotein (LDL)

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Hypercholesterolemia is a major risk factor for atherosclerosis and coronary heart disease (CHD).[1] Epidemiological and clinical studies have demonstrated that aggressive lowering of low-density lipoprotein cholesterol (LDL-C) reduces morbidity and mortality in patients with or without CHD.[1-3]

Vascular Calcification's Risk Factors in Haemodialysis Patients

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Cardiovascular diseases (CVD) are the main causes of death and hospitalization in patients affected by ESRD . The risk of death from CVD is already detectable in the early steps of chronic renal failure and it is from 20 to 30 times higher than in the general population. In ESRD patients the

Effect of Diabetic Medications on Bone Metabolism

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
The prevalence rate of diabetes among veterans is 16% in general and 27% at out medical center compared to 6.3% among United States population. Subjects with diabetes and prediabetes said to have increased bone loss compared to the general population. Pioglitazone, a thiazolidinedione, is a Food and

Acetylcarnitine and Insulin Sensitivity

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Decreased insulin sensitivity (e.g. insulin resistance) is a hallmark and a major pathogenic factor of type 2 diabetes. Diabetes often is related to a cluster of arterial hypertension, obesity, impaired glucose tolerance, dyslipidemia, coagulation abnormalities, albuminuria and increased

Study of 3,5-Diiodothyropropionic Acid (DITPA) in Hypercholesterolemic Patients

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
INTRODUCTION BACKGROUND: In recent years, the need to achieve increasingly ambitious therapeutic goals for dyslipidemias has prompted the search for more potent pharmacological agents to lower circulating atherogenic lipoprotein concentrations and enhance reverse cholesterol transport (RCT). While

Carotid Atherosclerosis Regression at Magnetic Resonance Assessment.

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
FULL PROTOCOL 1.0 SYNOPSIS The primary objective of this randomized, double blind, placebo controlled pilot study is to determine if therapies aimed at lowering LDL cholesterol (HMGCoA reductase inhibitor - simvastatin) or increasing HDL cholesterol (Niaspan) will induce regression of carotid
Pridružite se našoj
facebook stranici

Najkompletnija baza ljekovitog bilja potpomognuta znanošću

  • Radi na 55 jezika
  • Biljni lijekovi potpomognuti znanošću
  • Prepoznavanje bilja slikom
  • Interaktivna GPS karta - označite bilje na mjestu (uskoro)
  • Pročitajte znanstvene publikacije povezane s vašom pretragom
  • Pretražite ljekovito bilje po učincima
  • Organizirajte svoje interese i budite u toku s istraživanjem vijesti, kliničkim ispitivanjima i patentima

Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi.
* Svi podaci temelje se na objavljenim znanstvenim istraživanjima

Google Play badgeApp Store badge